TechFlow news, September 4 — Enzyme Finance, an on-chain asset management protocol, announced today its acquisition of a majority stake in DeFi protocol MYSO Finance. This acquisition will enable Enzyme to offer clients customized covered call strategies, further expanding its service offerings.
MYSO Finance is a protocol designed to bridge DeFi and traditional finance concepts. Its MYSO v2 version implements a trust-minimized lending protocol on EVM chains, featuring Zero Liquidation Lending (ZLL). This innovation allows users to borrow against crypto collateral without facing liquidation risk.
As a user-friendly DeFi asset management system, Enzyme provides seamless access for funds, investment clubs, DAO treasuries, and enterprises. By integrating various protocols and streamlining the asset management experience, Enzyme aims to reduce the complexity of interacting with DeFi and deliver a more seamless user experience.
